Ranked #1 Children's Hospital by U.S. News & World Report
MyPatients provides referring primary care providers with secure access to their patients’ information.
Boston Children's has launched the world's 1st program dedicated to offering hand transplants to children who qualify.
Innovation insider is a semi-monthly e-newsletter analyzes innovations at Boston Children’s, other academic medical centers and from industry.
Read the latest blog by a Boston Children's doctor, clinician or staff member.
Support the hospital with a donation that helps kids get the care they need.
If your child has been experiencing seizures that don’t respond to medication, a possible cause may be a dysembryoplastic neuroepithelial tumor (DNT). This is a rare, benign type of tumor that occurs in the tissues that cover the brain and spinal cord. The outlook for a child with DNT is generally good.
As you read further below, you will find general information about dysembryoplastic neuroepithelial tumors (DNT). To read summary information about brain tumors first, see the overview on brain tumors.
How Dana-Farber/Boston Children’s Cancer and Blood Disorders Center approaches DNT:
If your child is cared for at Boston Children’s, he’ll be seen through Dana-Farber/Boston Children's, an integrated pediatric oncology program through Dana-Farber Cancer Institute and Boston Children’s Hospital that provides—in one specialized program—all the services of both a leading cancer center and a pediatric hospital.
Our pediatric neuro-oncology, neurosurgical and neurology specialists at Dana-Farber/Boston Children's offer:
Through the Stop and Shop Neuro-Oncology Outcomes Clinic at Dana-Farber Cancer Institute, your child will be are able to meet with his entire care team at the same follow-up visit.
The future of pediatrics will be forged by thinking differently, breaking paradigms and joining together in a shared vision of tackling the toughest challenges before us.”